Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Aug;32(8):1265-77.
doi: 10.1007/s11064-007-9302-4. Epub 2007 Mar 31.

The study of Golgi apparatus in Alzheimer's disease

Affiliations
Review

The study of Golgi apparatus in Alzheimer's disease

Zhiping Hu et al. Neurochem Res. 2007 Aug.

Abstract

Alzheimer's disease is an irreversible, progressive neurodegenerative disorder leading invariably to death, usually within 7-10 years after diagnosis and is the leading cause of dementia in the elderly. Not only is Alzheimer's disease a tragic disease in which people suffer from neurodegeneration in the years to come, it also becomes an incredible burden on the public health system. However, there is currently no effective treatment to halt the progression or prevent the onset of Alzheimer's disease. This is partly due to the fact that the complex pathophysiology of Alzheimer's disease is not yet completely understood. Recently, Golgi apparatus is found to play an important role in Alzheimer's disease. In this review, we discuss the changes of Golgi apparatus during clinical progression and pathological development of Alzheimer's disease. First, changes of Golgi apparatus size in Alzheimer's disease are summarized. We then address the role of Golgi apparatus in the neuropathology of Alzheimer's disease. Finally, the role of Golgi apparatus in the pathogenesis of Alzheimer's disease is discussed. Understanding the contribution of Golgi apparatus dysfunction to Alzheimer's disease and its pathophysiological basis will significantly impact our ability to develop more effective therapies for Alzheimer's disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Biol. 1999 Oct 18;147(2):277-94 - PubMed
    1. Exp Cell Res. 2000 Mar 15;255(2):192-206 - PubMed
    1. J Biol Chem. 2002 May 3;277(18):16278-84 - PubMed
    1. Nat Rev Neurosci. 2002 Nov;3(11):862-72 - PubMed
    1. Nature. 2000 Sep 7;407(6800):48-54 - PubMed

LinkOut - more resources